Aquestive Therapeutics News

Aquestive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wargacki Stephen

May 13 12:44

Aquestive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Jenkins Abigail L.

May 13 12:44

Aquestive Therapeutics | 8-K: Current report

May 8 13:35

Aquestive Therapeutics | 10-Q: Quarterly report

May 7 15:31

Aquestive Therapeutics | 8-K: Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 7 15:28

Aquestive Therapeutics | 8-K: Current report

Apr 29 08:33

Aquestive Therapeutics | ARS: Annual Report to Security Holders

Apr 26 15:39

Aquestive Therapeutics | DEFA14A: Others

Apr 26 15:39

Aquestive Therapeutics | DEF 14A: Definitive information statements

Apr 26 15:37

Aquestive Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Jenkins Abigail L.

Apr 26 08:23

Aquestive Therapeutics | 424B2: Prospectus

Apr 24 05:28

Aquestive Therapeutics | 424B2: Prospectus

Apr 24 05:28

Aquestive Therapeutics | EFFECT: Others

Apr 24 05:09

Aquestive Therapeutics | 8-K: Current report

Apr 22 15:14

Aquestive Therapeutics | CORRESP: CORRESP

Apr 19 13:21

Aquestive Therapeutics | CORRESP: CORRESP

Apr 19 13:21

Aquestive Therapeutics | CORRESP: CORRESP

Apr 16 13:21

Aquestive Therapeutics | UPLOAD: Others

Apr 8 13:21

Aquestive Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 3 16:31

Aquestive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(6.5%),VHCP Co-Investment Holdings III, LLC(6.5%), etc.

Apr 1 17:23